Table 3 The variation of the ET-1 concentration among patients according risk factors
Populations and risk factors | ET-1 (nM/L) | p | |
|---|---|---|---|
Gender | Men (n = 121) | 17.4 ± 4.6 | <0.00001 |
Women (n = 36) | 7.8 ± 2.3 | ||
Hypertension | Yes (n = 138) | 16.4 ± 3.3 | <0.00001 |
No (n = 19) | 6.6 ± 1.9 | ||
Diabetes | Yes (n = 101) | 15 ± 5.1 | NS |
No (n = 56) | 15.6 ± 3.8 | ||
Tobacco | Yes (n = 98) | 11.6 ± 3 | <0.00001 |
No (n = 59) | 21.2 ± 6.1 | ||
Personal cardiovascular antecedents | Yes (n = 104) | 15.3 ± 4.4 | NS |
No (n = 53) | 15 ± 2.8 | ||
Obesity | Yes (n = 82) | 12.2 ± 5.3 | <0.001 |
No (n = 75) | 18.2 ± 4 | ||
Dyslipidemia | Yes (n = 63) | 11.8 ± 1.6 | <0.00001 |
No (n = 94) | 17 .5 ± 4.6 | ||
Alcohol | Yes (n = 52) | 16 ± 4.1 | NS |
No (n = 105) | 14.8 ± 3.8 | ||
Sedentarity | Yes (n = 67) | 15.7 ± 3.7 | NS |
No (n = 90) | 14.9 ± 2.4 | ||